About DSIpharma
DSIpharma is a private company based in Wilmington, Delaware, incorporated in 2025 in Delaware. It has reported $951,250 raised in one offering on Form D since July 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 17, 2025 | Jul 15, 2025amended Oct 2, 2026 | $951,250of $3.0M target | 18 | $52,847 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on DSIpharma's Form D filed Oct 2, 2026.
MR
Mark Ridall
Executive Officer and Director
KL